AVIEW LCS vs Clarius AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW LCS

by Coreline Soft

Clarius AI

by Clarius

AI Verdict

AVIEW LCS is an AI-powered solution focused on the detailed analysis of CT scans for lung cancer screening, COPD, and coronary artery calcification. In contrast, Clarius AI enhances the functionality of handheld ultrasound scanners by improving image quality, automating measurements, and providing real-time guidance across various specialties. While both fall under the umbrella of Radiology AI, their distinct imaging modalities and specific clinical applications make them adjacent rather than direct competitors.

Choose AVIEW LCS if…

Choose AVIEW LCS if your institution requires a robust, AI-driven solution for comprehensive lung cancer screening and cardiopulmonary assessment based on low-dose CT scans. This tool is ideal for radiology, pulmonology, and oncology departments needing automated nodule detection, Lung-RADS classification, and integrated analysis of emphysema and coronary artery calcification for efficient workflow and precise follow-up.

View AVIEW LCS →

Choose Clarius AI if…

Choose Clarius AI if you need highly portable, AI-enhanced ultrasound capabilities for point-of-care diagnostics, real-time guidance, and training across diverse clinical settings. This solution is perfect for emergency medicine, OB/GYN, or general practitioners seeking an affordable, handheld ultrasound system with features like automatic image optimization, anatomical overlays, and semi-automatic measurements to streamline examinations and improve diagnostic confidence on the go.

View Clarius AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW LCS	Clarius AI
Pricing	Subscription or one-off payment	Unknown
Deployment	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)	Cloud, Mobile App
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Clarius AI

Clarius AI focuses on real-time guidance, voice controls, and portability for point-of-care ultrasound, making it highly usable for a broader range of clinicians in dynamic settings. While AVIEW LCS streamlines radiology workflows, Clarius's features are more directly aimed at simplifying immediate user interaction during the scanning process.

Clinical Value

AVIEW LCS

AVIEW LCS provides direct, quantitative diagnostic and prognostic insights for critical conditions like lung cancer, COPD, and coronary artery disease from CT scans, offering high-stakes clinical value. Clarius AI improves the general utility and accessibility of ultrasound, which is valuable but less specific in its direct diagnostic impact compared to AVIEW LCS.

Pricing & Value

Clarius AI

Clarius AI offers clear and transparent pricing, including scanner costs and a comprehensive membership that adds significant value through advanced software, AI tools, and cloud services. AVIEW LCS lacks pricing transparency, making it impossible to evaluate its value proposition without direct inquiry.

Enterprise Readiness

AVIEW LCS

AVIEW LCS offers more comprehensive deployment options, including cloud, hybrid, local hardware, and virtualized solutions, which are often critical for large healthcare enterprises with diverse IT infrastructures and data governance requirements. While Clarius AI offers cloud and mobile deployment with PACS integration, its flexibility is more limited.

Innovation

Clarius AI

Clarius AI demonstrates significant innovation by integrating advanced AI, real-time guidance, and voice control into portable, handheld ultrasound devices, effectively democratizing access to high-quality imaging at the point of care. AVIEW LCS is innovative in its multi-disease assessment from a single CT, but Clarius's approach is more disruptive in its delivery model.

Support & Docs

Clarius AI

Clarius AI provides clear evidence of dedicated support resources, including an Education Portal, Support Center, user manuals, and direct contact information, which are crucial for user adoption and ongoing success. AVIEW LCS's available information focuses more on automated reporting features rather than explicit support for the software users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW LCS	Clarius AI
Name	AVIEW LCS	Clarius AI
Company	Coreline Soft Co.	Clarius Mobile Health
Tagline	AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment	Pioneer in AI-powered handheld ultrasound, making accurate, easy-to-use, and affordable ultrasound tools available to all medical professionals.
Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, OB/GYN AI, Radiology & Imaging AI
Specialties	Cardiology, Oncology, Pulmonology, Radiology	Emergency Medicine, Obstetrics & Gynecology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and Clarius AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities do AVIEW LCS and Clarius AI support?

AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules, COPD, and coronary artery calcification from low-dose CT scans. Clarius AI, on the other hand, is integrated into handheld ultrasound scanners and an app, designed to enhance image quality and automate measurements during ultrasound examinations.

What are the primary clinical applications and specialties for each tool?

AVIEW LCS focuses on lung cancer screening and cardiopulmonary assessment, including automated lung nodule detection, Lung-RADS classification, emphysema quantification, and coronary artery calcification scoring, serving specialties like Cardiology, Oncology, Pulmonology, and Radiology. Clarius AI provides features like auto preset AI, real-time AI labeling, and semi-automatic measurements for various structures across specialties such as Emergency Medicine, Obstetrics & Gynecology, and Radiology.

What specific AI functionalities do these tools provide?

AVIEW LCS offers automated lung nodule detection and analysis, Lung-RADS classification, nodule volume quantification, 3D segmentation, emphysema quantification, and coronary artery calcification scoring. Clarius AI includes Auto Preset AI for image optimization, real-time AI labeling and anatomical overlays for guidance, and semi-automatic measurements for various structures.

How do AVIEW LCS and Clarius AI handle reporting and integration with existing systems?

AVIEW LCS provides comprehensive, automated report generation and integrates with PACS/RIS and third-party platforms. Clarius AI offers integrated patient reports and CPT medical codes for streamlined billing, along with DICOM/PACS integration as part of its membership.